2Año·

$ABCL (+1,69 %) Does anyone know how AbCellera has generated revenue in the past and why it feels like it is currently down to 0?

3 Comentarios

Alexander@AlexanderJokiel

2Año

Had a drug with Eli Lilly regarding corona antibodies, which had an emergency approval or similar, after corona is history, sales have gone to zero

•

N@Khlmysee

2Año

@AlexanderJokiel big thanks! What do you think of the stock/company? Don't "worry", I will inform myself today. :)

••

Alexander@AlexanderJokiel

2Año

@Kohlmeyse the principle is good, you avoid unnecessary costs in the laboratory by testing drug candidates in silico and examining them later in the laboratory. I still had abcellera in my portfolio until a few days ago, but I said goodbye to them because in my opinion there is too little in the pipeline and they still need some time before they can be brought to market. It remains on my watchlist, if something changes at some point it could come back into depot,

•